Blood tumor marker used to monitor treatment response and recurrence in pancreatic and biliary tract cancers. Not used for screening.
Indication
- Monitoring treatment response in diagnosed pancreatic cancer
- Follow-up of biliary tract cancer (cholangiocarcinoma)
- Monitoring recurrence after surgery
- Assessment of treatment efficacy during chemotherapy
- Supportive test in differential diagnosis of pancreatic mass (together with clinical findings)
- Routine follow-up in patients responding to treatment
Preparation
- Special fasting is not required; however, 8-12 hours of fasting may be advised when ordered with combined tests
- Current medications and history of jaundice should be reported
- Bringing previous tumor marker results
How it's performed
- A venous blood sample is drawn from the arm
- Serum is separated and measurement is performed by immunological method
- Result is reported in U/mL; threshold values vary by laboratory
- Interpretation is performed together with clinical findings and imaging
Post-procedure
- Repeat measurement at defined intervals during the treatment process
- Rising values are evaluated with imaging
- Results are discussed in person with the physician
- Awareness that values may be falsely elevated in jaundice (biliary obstruction)
Risks
- Minor bruising or tenderness related to blood draw
- False elevation in benign conditions such as jaundice, pancreatitis, and cholangitis
- In Lewis antigen-negative individuals (~5-10%), test results may be unreliable
- Use as a screening test may lead to erroneous results
FAQ
If CA 19-9 is high, does it definitely mean cancer?
No. It can also rise in benign conditions such as pancreatitis, jaundice, cholangitis, and liver diseases. It does not establish a diagnosis on its own.
Can I have it done for pancreatic cancer screening?
CA 19-9 is not recommended as a screening test. It is used only in patients with a confirmed diagnosis for treatment monitoring and recurrence follow-up.
When are the results available?
Most laboratories provide results the same day or within 1 business day.
Related Information
Related Medical Services
Other services in the same specialty or with similar indications you may want to explore.
Amylase and lipase
Medical Biochemistry
Amylase and lipase — blood tests used in the diagnosis of pancreatic inflammation (pancreatitis).
Complete blood count
Medical Biochemistry
Complete blood count (CBC) — a basic screening test that measures the numbers and ratios of blood cells.
Fasting Blood Glucose
Medical Biochemistry
Fasting glucose test — a basic laboratory test for diabetes screening and blood sugar monitoring.
HbA1c
Medical Biochemistry
HbA1c — glycated hemoglobin test that reflects average blood glucose over the past 2-3 months.
Lipid panel
Medical Biochemistry
Lipid panel — measurement of total cholesterol, HDL, LDL, and triglycerides for cardiovascular risk assessment.
Urine Culture
Medical Biochemistry
Urine culture — identification of the bacterium growing in the urine and determination of antibiotic susceptibility.
Blood Culture
Medical Biochemistry
Blood culture — identification of bacteria or fungi in the bloodstream and antibiotic susceptibility testing.
Erythrocyte Sedimentation Rate (ESR)
Medical Biochemistry
ESR — a blood test that measures the rate at which red blood cells settle, used to assess inflammation in the body.